Log in

NASDAQ:NXTCNextCure Stock Price, Forecast & News

$17.88
-0.30 (-1.65 %)
(As of 07/10/2020 04:00 PM ET)
Add
Compare
Today's Range
$17.55
Now: $17.88
$18.45
50-Day Range
$18.18
MA: $25.69
$34.54
52-Week Range
$16.04
Now: $17.88
$109.00
Volume710,200 shs
Average Volume445,147 shs
Market Capitalization$492.06 million
P/E RatioN/A
Dividend YieldN/A
Beta-0.05
There is no company description available for NextCure Inc.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 4.4Community Rank: 2.8Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.64 out of 5 stars


Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:NXTC
CUSIPN/A
CIKN/A
Phone240-399-4900

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$6.35 million
Book Value$14.13 per share

Profitability

Net Income$-33,740,000.00

Miscellaneous

EmployeesN/A
Market Cap$492.06 million
Next Earnings Date8/10/2020 (Estimated)
OptionableNot Optionable

Receive NXTC News and Ratings via Email

Sign-up to receive the latest news and ratings for NXTC and its competitors with MarketBeat's FREE daily newsletter.

NextCure (NASDAQ:NXTC) Frequently Asked Questions

How has NextCure's stock been impacted by COVID-19 (Coronavirus)?

NextCure's stock was trading at $38.22 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, NXTC shares have decreased by 53.2% and is now trading at $17.88. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of NextCure?

9 Wall Street analysts have issued "buy," "hold," and "sell" ratings for NextCure in the last year. There are currently 2 hold ratings and 7 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for NextCure.

When is NextCure's next earnings date?

NextCure is scheduled to release its next quarterly earnings announcement on Monday, August 10th 2020. View our earnings forecast for NextCure.

How were NextCure's earnings last quarter?

NextCure Inc (NASDAQ:NXTC) posted its quarterly earnings results on Thursday, May, 7th. The company reported $0.33 EPS for the quarter, beating the Thomson Reuters' consensus estimate of ($0.44) by $0.77. The firm earned $22.38 million during the quarter, compared to the consensus estimate of $1.30 million. NextCure had a negative net margin of 65.22% and a negative return on equity of 7.12%. View NextCure's earnings history.

What price target have analysts set for NXTC?

9 equities research analysts have issued 1 year target prices for NextCure's stock. Their forecasts range from $40.00 to $87.00. On average, they expect NextCure's share price to reach $64.67 in the next twelve months. This suggests a possible upside of 261.7% from the stock's current price. View analysts' price targets for NextCure.

Has NextCure been receiving favorable news coverage?

Media coverage about NXTC stock has been trending very negative this week, according to InfoTrie Sentiment Analysis. InfoTrie identifies negative and positive press coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. NextCure earned a news impact score of -3.2 on InfoTrie's scale. They also gave news articles about the company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an effect on the company's share price in the next several days. View the latest news about NextCure.

Are investors shorting NextCure?

NextCure saw a increase in short interest during the month of June. As of June 30th, there was short interest totaling 1,740,000 shares, an increase of 41.5% from the June 15th total of 1,230,000 shares. Based on an average trading volume of 301,900 shares, the days-to-cover ratio is presently 5.8 days. Currently, 10.7% of the company's shares are sold short. View NextCure's Current Options Chain.

Who are some of NextCure's key competitors?

What other stocks do shareholders of NextCure own?

Based on aggregate information from My MarketBeat watchlists, some companies that other NextCure investors own include Amgen (AMGN), Alibaba Group (BABA), CVS Health (CVS), Dicerna Pharmaceuticals (DRNA), UnitedHealth Group (UNH), Honeywell International (HON), Johnson & Johnson (JNJ), NVIDIA (NVDA), AT&T (T) and Arena Pharmaceuticals (ARNA).

When did NextCure IPO?

(NXTC) raised $75 million in an initial public offering on Thursday, May 9th 2019. The company issued 5,000,000 shares at $14.00-$16.00 per share. Morgan Stanley, BofAMerrill Lynch, Pierce and Piper Jaffray acted as the underwriters for the IPO.

What is NextCure's stock symbol?

NextCure trades on the NASDAQ under the ticker symbol "NXTC."

How do I buy shares of NextCure?

Shares of NXTC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is NextCure's stock price today?

One share of NXTC stock can currently be purchased for approximately $17.88.

How big of a company is NextCure?

NextCure has a market capitalization of $492.06 million and generates $6.35 million in revenue each year. The company earns $-33,740,000.00 in net income (profit) each year or ($2.15) on an earnings per share basis.

What is NextCure's official website?

The official website for NextCure is www.nextcure.com.

How can I contact NextCure?

NextCure's mailing address is 9000 VIRGINIA MANOR ROAD SUITE 200, BELTSVILLE MD, 20705. The company can be reached via phone at 240-399-4900 or via email at [email protected]

This page was last updated on 7/12/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.